ADMP - Adamis Pharmaceuticals Corp
Close
0.7751
0.007 0.852%
Share volume: 119,837
Last Updated: Thu 07 Sep 2023 10:00:00 PM CEST
Pharmaceutical Preparation Manufacturing :
-2.88%
PREVIOUS CLOSE
CHG
CHG%
$0.77
0.01
0.86%
Summary score
34%
Profitability
43%
Dept financing
40%
Liquidity
10%
Performance
30%
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
Long-term ratios 2019 - 2023
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-36.79%
Return on assets
-26.34%
Return on sales
-1568.29%
Return on invested capital
122.6%
Total debt ratio
55.13%
Debt ratio change over timeo
-0.81%
Current Ratio
1.79%
Quick Ratio
1.66%
Cash Position Ratio
1.19%
Short-term ratios 2022 - 2023
The data are presented for the financials results of the quarters of the last year.
Return on equity
84.87%
Return on assets
-48.72%
Return on sales
-5369.8%
Return on invested capital
72.79%
Total debt ratio
111.59%
Debt ratio change over timeo
0.75%
Current Ratio
1.03%
Quick Ratio
0.95%
Cash Position Ratio
0.38%
Last quarter ratios 2023
The data are presented for the financials results of the last quarter.
Return on equity
93.89%
Return on assets
-70.82%
Return on sales
-442.37%
Return on invested capital
78.31%
Total debt ratio
204.94%
Debt ratio change over time
1.62%
Current Ratio
0.58%
Quick Ratio
0.53%
Cash Position Ratio
0.24%
Performance ratios (change over 4 years) 2019 - 2023
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-58.42%
Return on assets
-105.93%
Return on sales
-1244.51%
Return on invested capital
-26.71%
Total debt ratio
-81.11%
Debt ratio change over time
-0.81%
Current Ratio
-1.59%
Quick Ratio
-1.4%
Cash Position Ratio
-1.5%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | ADMP | VLON | ELAT | RETA |
|---|---|---|---|---|
| Return on equity | -36.79% | 0% | 0% | -113.97% |
| Return on assets | -26.34% | 0% | 0% | -11.86% |
| Return on sales | -1568.29% | 0% | 0% | -8138.12% |
| Return on invested capital | 122.6% | 0% | 0% | 12.38% |
| Profitability | 25% | 0% | 75% | 3% |
| Total debt ratio | 55.13% | 0% | 0% | 82.24% |
| Debt ratio change over time | -0.81% | 0% | 0% | -0.64% |
| Dept financing | 17% | 0% | 25% | 25% |
| Current Ratio | 1.03% | 0% | 0% | 8.05% |
| Quick Ratio | 0.95% | 0% | 0% | 8.05% |
| Cash Position Ratio | 0.38% | 0% | 0% | 7.86% |
| Liquididy | 15% | 0% | 0% | 75% |
| Short-term ratios | ADMP | VLON | ELAT | RETA |
|---|---|---|---|---|
| Return on equity | 84.87% | 0% | 0% | -409.38% |
| Return on assets | -48.72% | 0% | 0% | -15.5% |
| Return on sales | -5369.8% | 0% | 0% | -26031.24% |
| Return on invested capital | 72.79% | 0% | 0% | -122.74% |
| Profitability | 50% | 0% | 50% | 0% |
| Total debt ratio | 111.59% | 0% | 0% | 107.48% |
| Debt ratio change over time | 0.75% | 0% | 0% | -1.94% |
| Dept financing | 50% | 0% | 0% | 24% |
| Current Ratio | 1.03% | 0% | 0% | 8.05% |
| Quick Ratio | 0.95% | 0% | 0% | 8.05% |
| Cash Position Ratio | 0.38% | 0% | 0% | 7.86% |
| Liquididy | 7% | 0% | 0% | 75% |